Suppr超能文献

支气管热成形术:激活情况可预测反应。

Bronchial thermoplasty: activations predict response.

作者信息

Langton David, Sha Joy, Ing Alvin, Fielding David, Thien Francis, Plummer Virginia

机构信息

Department of Thoracic Medicine, Frankston Hospital, 2 Hastings Road, Frankston, VIC, 3199, Australia.

Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.

出版信息

Respir Res. 2017 Jul 4;18(1):134. doi: 10.1186/s12931-017-0617-7.

Abstract

BACKGROUND

Bronchial thermoplasty (BT) is an emerging bronchoscopic intervention for the treatment of severe asthma. The predictive factors for clinical response to BT are unknown. We examined the relationship between the number of radiofrequency activations applied and the treatment response observed.

METHODS

Data were collected from 24 consecutive cases treated at three Australian centres from June 2014 to March 2016. The baseline characteristics were collated along with the activations delivered. The primary response measure was change in the Asthma Control Questionnaire-5 (ACQ-5) score measured at 6 months post BT. The relationship between change in outcome parameters and the number of activations delivered was explored.

RESULTS

All patients met the ERS/ATS definition for severe asthma. At 6 months post treatment, mean ACQ-5 improved from 3.3 ± 1.1 to 1.5 ± 1.1, p < 0.001. The minimal clinically significant improvement in ACQ-5 of ≥0.5 was observed in 21 out of 24 patients. The only significant variable that differed between the 21 responders and the three non-responders was the number of activations delivered, with 139 ± 11 activations in the non-responders, compared to 221 ± 45 activations in the responders (p < 0.01). A significant inverse correlation was found between change in ACQ-5 score and the number of activations, r = -0.43 (p < 0.05).

CONCLUSIONS

The number of activations delivered during BT has a role in determining clinical response to treatment.

摘要

背景

支气管热成形术(BT)是一种新兴的用于治疗重度哮喘的支气管镜介入治疗方法。BT临床反应的预测因素尚不清楚。我们研究了射频激活次数与观察到的治疗反应之间的关系。

方法

收集了2014年6月至2016年3月在澳大利亚三个中心连续治疗的24例患者的数据。整理了基线特征以及所进行的激活次数。主要反应指标是BT术后6个月测量的哮喘控制问卷-5(ACQ-5)评分的变化。探讨了结果参数变化与激活次数之间的关系。

结果

所有患者均符合欧洲呼吸学会/美国胸科学会(ERS/ATS)对重度哮喘的定义。治疗后6个月,ACQ-5评分均值从3.3±1.1改善至1.5±1.1,p<0.001。24例患者中有21例观察到ACQ-5至少改善0.5的最小临床显著改善。21例有反应者和3例无反应者之间唯一显著不同的变量是激活次数,无反应者为139±11次激活,有反应者为221±45次激活(p<0.01)。发现ACQ-5评分变化与激活次数之间存在显著负相关,r=-0.43(p<0.05)。

结论

BT期间的激活次数在决定治疗的临床反应中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28a6/5496290/7181ab692dca/12931_2017_617_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验